Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

16 Nov 2026 - 19 Nov 2026
08 Dec 2026 - 10 Dec 2026

Antibody-Free Blood Test Detects Rheumatic Heart Disease Biomarker

By HospiMedica International staff writers
Posted on 12 Nov 2026
Rheumatic heart disease (RHD) causes hundreds of thousands of deaths annually, disproportionately affecting children and young adults in low- and middle-income countries. More...
Early detection remains challenging in resource-limited settings, where specialized ultrasound equipment, laboratory infrastructure, and refrigerated antibody-based tests are often unavailable. To help overcome these barriers, researchers have developed an antibody-free blood-testing approach designed to detect cardiac inflammatory biomarkers without complex laboratory equipment.
 
Researchers at Ben-Gurion University of the Negev (BGU; Beersheba, Israel) developed a synthetic, antibody-free diagnostic probe for detecting rheumatic heart disease (RHD)-related biomarkers in blood. The polymer-based sensor uses an HPMA backbone modified with specific peptide ligands and near-infrared fluorescent dyes. By eliminating the need for biological antibodies, which are costly to produce and sensitive to heat degradation, the technology aims to support rapid point-of-care screening in rural and underserved communities.
 
The probe functions as an optical switch that generates a fluorescent signal when it encounters E-selectin, an adhesion molecule released into the bloodstream during active valvular inflammation. In its inactive state, the polymer remains tightly clustered, bringing the fluorescent dyes close enough to suppress their light emission. When the targeting peptides bind to E-selectin, the polymer uncoils, separating the dyes and triggering a measurable fluorescent signal detectable using standard microplate readers.
 
In laboratory testing, the probe successfully detected and quantified E-selectin directly in complex serum samples, producing a clear, dose-dependent fluorescent response. Current detection sensitivity is in the microgram range, with further optimization underway to achieve nanogram-level detection for early-stage disease assessment. The findings were published in ACS Sensors, with researchers from BGU, Massachusetts General Hospital, and Harvard Medical School contributing to the study.
 
Although no established blood biomarker currently exists for diagnosing RHD, researchers suggest that combining multiple biomarkers could help distinguish the disease from non-rheumatic valvular conditions and other inflammatory disorders. The same polymer platform could also be adapted to detect biomarkers associated with other vascular and inflammatory diseases by modifying its targeting peptides, potentially expanding its diagnostic applications.
 
“Current diagnostics depend heavily on delicate animal-derived antibodies that spoil if they aren't kept on ice. By replacing antibodies with robust synthetic polymers and peptides, we have created a platform that is inherently stable, significantly cheaper to manufacture and resilient to ambient temperatures. It is built specifically to survive real-world conditions where cold-chain logistics simply don't exist,” said professor Ayelet David, lead researcher at Ben-Gurion University of the Negev.

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.